T. Rowe Price crypto head Blue Macellari on Thursday argued AI has pulled the marginal crypto buyer away from crypto, and institutional adoption is moving too slowly to fill that gap. How AI Stole Crypto’s Marginal Buyer Macellari shared on Raoul Pal’s The Journeyman podcast that investors who previously bought Bitcoin (CRYPTO: BTC) or Solana […]
What’s Going on With Beyond Meat Stock On Wednesday?
Beyond Meat, Inc. (NASDAQ:BYND) shares are trading higher on Wednesday as the market reacts to a recent announcement regarding a 1-for-30 reverse stock split. This move aims to increase the stock price and potentially attract more investors, following a period of significant declines in share value. Announces 1-for-30 Reverse Stock Split Beyond Meat announced a […]
Elon Musk Envisions Massive Growth for SpaceX’s Starlink Amid AI and Robotics Surge
Space Exploration Technologies Corp. (NASDAQ:SPCX) CEO Elon Musk on Sunday outlined an aggressive long-term outlook for the company’s Starlink satellite internet service, saying that it could eventually generate more than $1 trillion in annual revenue by capturing a majority of internet traffic. Musk said the rapid expansion of artificial intelligence and robotics could drive a […]
Tom Lee Says ‘Just A Matter Of Time’ Until Bitcoin, ETH Get Going Again
Fundstrat’s Tom Lee said Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) fundamentals are pulling ahead of price after the October deleveraging burned investors, calling it “just a matter of time.” Why Lee And Horsley Say Fundamentals Are Outrunning Price? Lee replied on X to Bitwise CEO Hunter Horsley, who said after eight years in crypto […]
Top 3 Tech and Telecom Stocks That May Crash In Q3
As of Aug. 5, 2026, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices […]
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger
AstraZeneca Plc (NASDAQ:AZN) is reportedly in discussions with Bristol Myers Squibb (NYSE:BMY) to merge, potentially forming a pharmaceutical giant valued at nearly $400 billion. Talks Ongoing For Several Months The talks, which have been ongoing for several months, could soon result in a deal, though delays or a collapse remain possible, according to a report […]
Amazon’s AI Bet Wins Big As Analyst Sees $1 Trillion AWS Opportunity
Amazon.com, Inc. (NASDAQ:AMZN) stock gained over 15% on Friday as investors reacted to a double beat in quarterly results and upbeat cloud/AI commentary. BNP Paribas analyst Nick Jones said Amazon delivered a strong second quarter, with AWS momentum supporting higher AI-related investment and a path to a much larger cloud opportunity. AWS Strength Supports The […]
Procter & Gamble Reports Flat Organic Sales Amid Rising Costs
Procter & Gamble Company (NYSE:PG) shares are trading lower after the company reported mixed fourth-quarter results and issued FY27 guidance below estimates. Details Adjusted earnings per share of $1.43, beating the analyst consensus estimate of $1.41. Sales rose 2% year over year (Y/Y) to $21.203 billion, which came below the consensus estimate of $21.379 billion. Sales benefited from favorable […]
Newsletter
Top 3 Real Estate Stocks That May Plunge In Q1
January 27, 2025
As of Jan. 27, 2025, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices […]
Read More